Heteromultimeric ion channel receptor and uses thereof
AssigneeMcGill University
InventorsPhilippe Seguela, Kazimierz Babinski
Life of this patent
Estimating the term…
Loading patent…
AssigneeMcGill University
InventorsPhilippe Seguela, Kazimierz Babinski
Estimating the term…
The present invention describes a heteromultimeric proton-gated ion channel (herein called ASIC-2S.2) with distinctive properties. Compositions and methods are provided for producing and expressing functional ASIC-2S.2 channels, composed of ASIC2A and ASIC3 subunits. The invention also provides genetically engineered expression vectors comprising the nucleic acid sequences encoding both ASIC2A and ASIC3 and host cells coexpressing both ASIC2A and ASIC3 subunits. Also provided herein are genetically engineered nucleic acids encoding chimeric proton-gated ion channels comprised of at least two different subunits, as well as expression vectors and host cells comprising said engineered nucleic acids. The invention also provides for the use of ASIC-2S.2, as well as agonists, antagonists or antibodies specifically binding ASIC-2S.2, in the diagnosis, prevention and treatment of diseases associated with expression of ASIC-2S.2. Also are disclosed methods of influencing electrophysiological, pharmacological and/or functional properties of ASIC-2S.2 as well as methods for screening for substances having ion-channel modulating activity or substances capable of disrupting subunit association or interaction.
A purified heteromultimeric acid-sensing ion channel comprising:
A process for producing a heteromultimeric acid-sensing ion channel comprising, culturing a host cell that expresses a recombinant ASIC2A polypeptide comprising an amino acid sequence at least 90% identical to the amino acid sequence set forth in SEQ ID NO:2 or SEQ ID NO:6, and a recombinant ASIC3 polypeptide comprising an amino acid sequence at least 90% identical to the amino acid sequence set forth in SEQ ID NO:4 or SEQ ID NO:8, under conditions sufficient to express the recombinant ASIC2A and ASIC3 polypeptides.
Dependencies are inferred from the claim text.